Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

We don't pay much attention to our eyes until there's a problem. Most of us wait until daily life or reading becomes blurry, "floaters" invade our vision or glare from the headlights of oncoming cars ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Age-related macular degeneration (AMD) AMD is a common eye condition that happens as you get older. It affects the macula, ...

MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.

Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Therapeutics announced that the first patients have been enrolled across multiple sites in the 4FRONT-1 Phase 3 clinical ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

SB-007 addresses the root cause ofStargardt disease with the potential to treat all patients across all ABCA4 mutations SB-007 is the first dual AAV gene therapy in clinical ...